- Home
- LFT vs CBUS Comparison
LFT vs CBUS Comparison
Compare LFT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFT | CBUS |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Agricultural Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 208.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | LFT | CBUS |
|---|---|---|
| Price | $1.37 | $3.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 134.0K | ★ 548.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.68% | N/A |
| EPS Growth | N/A | ★ 58.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,262,000.00 |
| Revenue This Year | $124.75 | N/A |
| Revenue Next Year | N/A | $99.13 |
| P/E Ratio | $13.49 | ★ N/A |
| Revenue Growth | N/A | ★ 134.56 |
| 52 Week Low | $1.26 | $1.09 |
| 52 Week High | $2.84 | $4.19 |
Technical Indicators
Market Signals| Indicator | LFT | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 64.24 |
| Support Level | $1.26 | $1.34 |
| Resistance Level | $1.41 | N/A |
| Average True Range (ATR) | 0.04 | 0.30 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 58.33 | 67.53 |
Price Performance
Historical ComparisonAbout LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.